Linked Data API

Show Search Form

Search Results

100022
star this property registered interest false more like this
star this property date less than 2014-10-15more like thisremove minimum value filter
star this property answering body
Department of Health more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Patient Choice Schemes more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps he is taking to promote patient choice. more like this
star this property tabling member constituency Stroud more like this
star this property tabling member printed
Neil Carmichael more like this
star this property uin 905559 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2014-10-21more like thismore than 2014-10-21
star this property answer text <p>We are committed to patients having greater choice and control over their healthcare, as this can help drive up standards and improve patient care.</p><p> </p><p> </p><p> </p><p>We believe that patient empowerment is vital to the National Health Service in the 21st century. This Government is committed to continuing to develop digital platforms to enable this to happen, such as My NHS and the NHS e-Referral Service.</p><p> </p> more like this
star this property answering member constituency Mid Norfolk remove filter
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-10-21T16:00:56.1397924Zmore like thismore than 2014-10-21T16:00:56.1397924Z
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property tabling member
4104
unstar this property label Biography information for Neil Carmichael more like this
100186
star this property registered interest false more like this
star this property date less than 2014-10-21more like thismore than 2014-10-21
star this property answering body
Department of Health more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Patients: Safety more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, whether missed or inadequate hydrocortisone administration is included in the NHS list of Never Events. more like this
star this property tabling member constituency Oxford East more like this
star this property tabling member printed
Mr Andrew Smith more like this
star this property uin 211233 more like this
star this property answer
answer
unstar this property is ministerial correction true more like this
unstar this property date of answer less than 2014-10-28more like thismore than 2014-10-28
star this property answer text <p>Missed or inadequate hydrocortisone administration is not currently included in the list of ‘never events’.</p><p> </p><p> </p><p> </p><p>We can confirm that the current list of Never Events is under review and there is a consultation underway which opened online on the 6 October 2014 and closes on 31 October 2014.</p><p> </p> more like this
star this property answering member constituency Mid Norfolk remove filter
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-10-28T15:28:25.797Zmore like thismore than 2014-10-28T15:28:25.797Z
star this property question first ministerially corrected
less than 2014-10-28T16:30:53.2329022Zmore like thismore than 2014-10-28T16:30:53.2329022Z
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property previous answer version
24770
star this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison more like this
star this property answering member 3918
star this property tabling member
95
unstar this property label Biography information for Mr Andrew Smith more like this
100402
star this property registered interest false more like this
star this property date less than 2014-10-22more like thismore than 2014-10-22
star this property answering body
Department of Health more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Paralysis more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps he has taken to support University College London in its work to enable people who have been paralysed to regain the ability to walk. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 211576 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2014-10-27more like thismore than 2014-10-27
star this property answer text <p>The Department’s National Institute for Health Research (NIHR) funds 11 biomedical research centres that conduct translational research to transform scientific breakthroughs into benefits for patients. These centres are formed through partnerships between England’s leading National Health Service organisations and universities.</p><p> </p><p> </p><p> </p><p>The NIHR is investing £110 million over five years (2012-17) in the NIHR biomedical research centre at University College London Hospitals NHS Foundation Trust and University College London. The centre is supporting research on the use of cells from the lining of the nose to repair damaged nerves in the spinal cord.</p><p> </p><p><strong> </strong></p><p> </p> more like this
star this property answering member constituency Mid Norfolk remove filter
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-10-27T16:53:22.0851128Zmore like thismore than 2014-10-27T16:53:22.0851128Z
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
100411
star this property registered interest false more like this
star this property date less than 2014-10-22more like thismore than 2014-10-22
star this property answering body
Department of Health more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Cystic Fibrosis more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps the Government is taking to support research into new treatments for people with cystic fibrosis. more like this
star this property tabling member constituency Barnsley Central more like this
star this property tabling member printed
Dan Jarvis more like this
star this property uin 211584 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2014-10-27more like thismore than 2014-10-27
star this property answer text <p>The National Institute for Health Research (NIHR) Evaluation, Trials and Studies Coordinating Centre manages the Efficacy and Mechanism Evaluation programme. With funding from the Medical Research Council, this programme is currently supporting a £3.3 million trial of repeated application of gene therapy in patients with cystic fibrosis. The report of this trial is expected to be published in August 2015.</p><p> </p><p><strong> </strong></p><p> </p><p>A range of commercial and researcher-led cystic fibrosis treatment trials and studies are hosted by NIHR research infrastructure including the NIHR Clinical Research Network, NIHR biomedical research centres and units, and NIHR clinical research facilities for experimental medicine.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> more like this
star this property answering member constituency Mid Norfolk remove filter
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-10-27T16:52:12.8962611Zmore like thismore than 2014-10-27T16:52:12.8962611Z
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property tabling member
4243
unstar this property label Biography information for Dan Jarvis more like this
100816
star this property registered interest false more like this
star this property date less than 2014-10-23more like thismore than 2014-10-23
star this property answering body
Department of Health more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Terminal Illnesses more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what guidance his Department has issued to health technology appraisal committees on application of NICE's end of life criteria when appraising treatments for patients with terminal illness. more like this
star this property tabling member constituency Redcar more like this
star this property tabling member printed
Ian Swales more like this
star this property uin 211809 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2014-10-28more like thismore than 2014-10-28
star this property answer text <p>The Department has not issued any such guidance. The National Institute for Health and Care Excellence is an independent body and is responsible for the development of its methods and processes.</p><p> </p> more like this
star this property answering member constituency Mid Norfolk remove filter
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-10-28T14:56:20.6436753Zmore like thismore than 2014-10-28T14:56:20.6436753Z
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property tabling member
4045
unstar this property label Biography information for Ian Swales more like this
100817
star this property registered interest false more like this
star this property date less than 2014-10-23more like thismore than 2014-10-23
star this property answering body
Department of Health more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Terminal Illnesses more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what rationale lies behind NICE's advice that end-of-life criteria should only apply to medicines that extend life by at least three months. more like this
star this property tabling member constituency Redcar more like this
star this property tabling member printed
Ian Swales more like this
star this property uin 211807 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2014-10-28more like thismore than 2014-10-28
star this property answer text <p>In January 2009, the National Institute for Health and Care Excellence (NICE) issued supplementary advice to its appraisal committees on appraising treatments which may be life-extending for patients, with short life expectancy, and which are licensed for indications affecting small numbers of patients with incurable illnesses.</p><p> </p><p> </p><p> </p><p>This sets out the following three criteria that must all be satisfied for this supplementary advice to be applied:</p><p> </p><p>- the treatment is indicated for patients with a short life expectancy, normally less than 24 months;</p><p> </p><p>- there is sufficient evidence to indicate that the treatment offers an extension to life, normally of at least an additional three months, compared to current NHS treatment; and</p><p> </p><p>- the treatment is licensed or otherwise indicated, for small patient populations.</p><p> </p><p> </p><p> </p><p>These criteria were developed following public consultation and set out the circumstances when NICE considers it is appropriate for its appraisal committees to apply greater flexibility in their appraisal of these treatments.</p><p> </p><p> </p><p> </p><p>The advice has now been incorporated chapter 6 of <em>Guide to the methods of technology appraisal 2013 </em>which can be found at:</p><p> </p><p> </p><p> </p><p><a href="http://www.nice.org.uk/article/pmg9/chapter/6-the-appraisal-of-the-evidence-and-structured-decision-making" target="_blank">www.nice.org.uk/article/pmg9/chapter/6-the-appraisal-of-the-evidence-and-structured-decision-making</a></p><p> </p><p> </p><p> </p>
star this property answering member constituency Mid Norfolk remove filter
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-10-28T14:27:08.2752956Zmore like thismore than 2014-10-28T14:27:08.2752956Z
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property tabling member
4045
unstar this property label Biography information for Ian Swales more like this
93556
star this property registered interest false more like this
star this property date less than 2014-10-15more like thisremove minimum value filter
star this property answering body
Department of Health more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Pharmaceutical Price Regulation Scheme more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what discussions (a) he or (b) officials in his Department have had on reinvesting the industry rebate payments under the current Pharmaceutical Price Regulation Scheme into (i) healthcare services and (ii) medicines expenditure. more like this
star this property tabling member constituency Cambridge more like this
star this property tabling member printed
Dr Julian Huppert more like this
star this property uin 210807 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2014-10-22more like thismore than 2014-10-22
star this property answer text <p>The Pharmaceutical Price Regulation Scheme (PPRS) as agreed with the Association of the British Pharmaceutical Industry (ABPI) does not cover the onward financial flows of payments to the National Health Service which are subject to the Government accounting and budgeting rules in the normal way. In particular there was no agreement to hypothecate PPRS payments. The Department has subsequently had a number of discussions with the ABPI and NHS England about the onward financial flows.</p><p> </p><p> </p><p> </p><p>In respect of England, the anticipated payments in 2014-15 have been passed on to NHS England through the mandate and as such were included within commissioner allocations. The same is expected to apply in 2015-16. This means that the effect of the deal is felt across the NHS through the general funding allocations to clinical commissioning groups.</p><p> </p><p> </p><p> </p><p>The Government is committed to improving access to clinically and cost-effective medicines including innovative new medicines. As part of implementing the PPRS, NHS England and the ABPI are discussing how best to improve access to and optimise patient outcomes from these medicines.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p>
star this property answering member constituency Mid Norfolk remove filter
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-10-22T15:38:43.80669Zmore like thismore than 2014-10-22T15:38:43.80669Z
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property tabling member
3931
unstar this property label Biography information for Dr Julian Huppert more like this
93563
star this property registered interest false more like this
star this property date less than 2014-10-15more like thisremove minimum value filter
star this property answering body
Department of Health more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Surgical Mesh Implants more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, if he will review his policy on polypropylene transvaginal mesh implants in response to recent court judgements in the US. more like this
star this property tabling member constituency Newcastle upon Tyne East more like this
star this property tabling member printed
Mr Nicholas Brown more like this
star this property uin 210655 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2014-10-22more like thismore than 2014-10-22
star this property answer text <p>A working group, chaired by NHS England and including patient representatives, clinical representatives, the Department and the Medicines and Healthcare Products Regulatory Agency, has been set up to understand and address the concerns which have been raised about transvaginal mesh implants.</p><p> </p> more like this
star this property answering member constituency Mid Norfolk remove filter
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-10-22T15:19:50.645981Zmore like thismore than 2014-10-22T15:19:50.645981Z
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property tabling member
523
unstar this property label Biography information for Mr Nicholas Brown more like this
93566
star this property registered interest false more like this
star this property date less than 2014-10-15more like thisremove minimum value filter
star this property answering body
Department of Health more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Pharmaceutical Price Regulation Scheme more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what the value is of the rebate payments made by industry under the Pharmaceutical Price Regulation Scheme to date; and what proportion of that rebate has been reinvested in (i) healthcare services and (ii) medicines expenditure. more like this
star this property tabling member constituency Cambridge more like this
star this property tabling member printed
Dr Julian Huppert more like this
star this property uin 210640 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2014-10-20more like thismore than 2014-10-20
star this property answer text <p>The Department has received £74 million from members of the Pharmaceutical Price Regulation Scheme (PPRS) in respect of PPRS payments for the first quarter of the calendar year 2014 and £76 million in respect of the second quarter. The Department will publish aggregate information on sales reports and payments made under the scheme on a quarterly basis. The first two quarters PPRS payments were published in June and September 2014 respectively and can be found on the Government’s website at:</p><p> </p><p> </p><p> </p><p><a href="https://www.gov.uk/government/publications/pprs-quarterly-net-sales-and-payment-information" target="_blank">https://www.gov.uk/government/publications/pprs-quarterly-net-sales-and-payment-information</a></p><p> </p><p> </p><p> </p><p>In respect of England, the anticipated payments in 2014-15 have been passed on to NHS England through the Mandate and as such were included within commissioner allocations.</p><p> </p> more like this
star this property answering member constituency Mid Norfolk remove filter
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-10-20T16:15:30.8911788Zmore like thismore than 2014-10-20T16:15:30.8911788Z
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property tabling member
3931
unstar this property label Biography information for Dr Julian Huppert more like this
93568
star this property registered interest false more like this
star this property date less than 2014-10-15more like thisremove minimum value filter
star this property answering body
Department of Health more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Cancer more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what funding his Department provides for businesses and organisations conducting research into the benefits of natural products in cancer therapy and treatment. more like this
star this property tabling member constituency Belfast North more like this
star this property tabling member printed
Mr Nigel Dodds more like this
star this property uin 210719 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2014-10-22more like thismore than 2014-10-22
star this property answer text <p>The Government has funding mechanisms in place for research and development relating to cancer treatments.</p><p> </p><p> </p><p> </p><p>The Department's National Institute for Health Research (NIHR) welcomes funding applications for research into any aspect of human health, including the use of natural products in cancer treatment. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p> </p><p> </p><p> </p><p>The NIHR is investing £16 million over five years (to 2017) in 14 Experimental Cancer Medicine Centres (ECMCs) across England with joint funding from Cancer Research UK. These centres bring together laboratory and clinical patient-based research to speed up the development of innovative cancer therapies and individualise patient treatment. Researchers at the Leicester ECMC are currently looking at whether curcumin – found in turmeric – can improve drug response in patients with advanced bowel cancer.</p><p> </p><p> </p><p> </p><p>The NIHR manages the Efficacy and Mechanism Evaluation programme, which bridges the gap between preclinical studies and evidence of clinical efficacy. The aim is to secure the progress of new technologies and interventions through their early clinical trials and onto larger, later clinical trials. The programme is funded by the Medical Research Council (MRC) and the NIHR and is not currently funding any studies of the use of natural products in cancer treatment.</p><p> </p><p> </p><p> </p><p>Other sources of funding include the Biomedical Catalyst, which is a funding programme jointly operated by the MRC and Innovate UK. The programme provides responsive and effective support for the best translational life science opportunities arising. Grants are available to UK academics and small and medium enterprises seeking to move their research more quickly from discovery to commercialisation.</p><p> </p>
star this property answering member constituency Mid Norfolk remove filter
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-10-22T15:10:04.2140072Zmore like thismore than 2014-10-22T15:10:04.2140072Z
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property tabling member
1388
unstar this property label Biography information for Nigel Dodds more like this